InflaRx N.V. SEC filings IFRX
InflaRx N.V. has 289 filings in SEC EDGAR's recent list, going back to Jun 23, 2017. Its latest annual report, Form 20-F, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 14, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 6, 2026 | — |
| S-8 | Employee stock plan registration | Aug 6, 2026 | — |
| 424B5 | Prospectus supplement | May 7, 2026 | — |
| 424B5 | Prospectus supplement | May 6, 2026 | — |
| 424B5 | Prospectus supplement | Feb 18, 2025 | — |
| 424B5 | Prospectus supplement | Feb 13, 2025 | — |
| 424B5 | Prospectus supplement | Jun 28, 2024 | — |
| 424B5 | Prospectus supplement | Jul 12, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 30, 2023 | — |
| 424B5 | Prospectus supplement | Apr 13, 2023 | — |
| 424B5 | Prospectus supplement | Apr 11, 2023 | — |
| 424B5 | Prospectus supplement | Feb 26, 2021 | — |
| 424B5 | Prospectus supplement | Feb 24, 2021 | — |
| S-8 | Employee stock plan registration | Jul 30, 2020 | — |
| 424B5 | Prospectus supplement | Jul 20, 2020 | — |
| F-3/A | Form f-3/a | Jul 16, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 8, 2020 | — |
| F-3ASR | Filing | Mar 28, 2019 | — |
| 424B4 | Prospectus | May 7, 2018 | — |
| F-1 | Registration statement (foreign issuer) | May 2, 2018 | — |
| S-8 | Employee stock plan registration | Nov 17, 2017 | — |
| 424B4 | Prospectus | Nov 8, 2017 | — |
| F-1/A | Form f-1/a | Nov 7, 2017 | — |
| F-1/A | Amendment no. 3 to form f-1 | Oct 31, 2017 | — |
| F-1/A | Amendment no. 2 to form f-1 | Oct 30, 2017 | — |
| F-1/A | Form f-1/a | Oct 26, 2017 | — |
| F-1 | Registration statement (foreign issuer) | Oct 13, 2017 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IFRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Jena, Germany
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1708688
- Former names
- Fireman B.V. (until Nov 8, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.